These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16094084)

  • 21. Androgen receptor in prostate cancer: cause or cure?
    Bevan CL
    Trends Endocrinol Metab; 2005 Nov; 16(9):395-7. PubMed ID: 16202619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium.
    Sutherland BW; Knoblaugh SE; Kaplan-Lefko PJ; Wang F; Holzenberger M; Greenberg NM
    Cancer Res; 2008 May; 68(9):3495-504. PubMed ID: 18451178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pS2 (TFF1) expression in prostate carcinoma: correlation with steroid receptor status.
    Abdou AG; Aiad HA; Sultan SM
    APMIS; 2008 Nov; 116(11):961-71. PubMed ID: 19132993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genomic imprinting of insulin-like growth factor II in prostate cancer and its clinical significance].
    Liu ZW; Zhou FJ; Luo YM; Qin ZK; Wang DJ; Luo JH; Han H; Li YH; Wang H
    Ai Zheng; 2006 Jun; 25(6):765-70. PubMed ID: 16764778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogens and mechanisms of prostate cancer progression.
    Carruba G
    Ann N Y Acad Sci; 2006 Nov; 1089():201-17. PubMed ID: 17261768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GREB1 is a novel androgen-regulated gene required for prostate cancer growth.
    Rae JM; Johnson MD; Cordero KE; Scheys JO; Larios JM; Gottardis MM; Pienta KJ; Lippman ME
    Prostate; 2006 Jun; 66(8):886-94. PubMed ID: 16496412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atlas of dihydrotestosterone actions on the transcriptome of prostate in vivo.
    Ma C; Yoshioka M; Boivin A; Gan L; Takase Y; Labrie F; St-Amand J
    Prostate; 2009 Feb; 69(3):293-316. PubMed ID: 19023869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells.
    Chen M; Ni J; Chang HC; Lin CY; Muyan M; Yeh S
    Carcinogenesis; 2009 May; 30(5):841-50. PubMed ID: 19126643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
    Norman BH; Dodge JA; Richardson TI; Borromeo PS; Lugar CW; Jones SA; Chen K; Wang Y; Durst GL; Barr RJ; Montrose-Rafizadeh C; Osborne HE; Amos RM; Guo S; Boodhoo A; Krishnan V
    J Med Chem; 2006 Oct; 49(21):6155-7. PubMed ID: 17034120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hormones and osteoporosis update. Estrogen and bone remodeling].
    Kato S
    Clin Calcium; 2009 Jul; 19(7):951-6. PubMed ID: 19567990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flipping the epigenetic switch.
    Domann FE; Futscher BW
    Am J Pathol; 2004 Jun; 164(6):1883-6. PubMed ID: 15161624
    [No Abstract]   [Full Text] [Related]  

  • 33. Noninvasive bioluminescence imaging of normal and spontaneously transformed prostate tissue in mice.
    Lyons SK; Lim E; Clermont AO; Dusich J; Zhu L; Campbell KD; Coffee RJ; Grass DS; Hunter J; Purchio T; Jenkins D
    Cancer Res; 2006 May; 66(9):4701-7. PubMed ID: 16651422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
    Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones.
    Kirschenbaum A; Liu XH; Yao S; Narla G; Friedman SL; Martignetti JA; Levine AC
    Carcinogenesis; 2006 Feb; 27(2):216-24. PubMed ID: 16123118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells.
    Asirvatham AJ; Schmidt MA; Chaudhary J
    Prostate; 2006 Jun; 66(9):921-35. PubMed ID: 16541417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
    Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunolocalization of androgen receptors, estrogen alpha receptors, and estrogen beta receptors in experimentally induced canine prostatic hyperplasia.
    Gallardo F; Lloreta J; García F; Moll X; Baró T; González LA; Morote J; Reventos J; Mogas T
    J Androl; 2009; 30(3):240-7. PubMed ID: 19136389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
    Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
    Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Research at the Ulm University in prostate cancer].
    Rinnab L; Cronauer M; Spindler D; Hautmann RE; Küfer R
    Urologe A; 2007 Sep; 46(9):1071-7. PubMed ID: 17628778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.